A combination of osteoclast differentiation factor and macrophage- colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro

Endocrinology

Volumn 139, Issue 10, 1998, Pages 4424-4427

  Quinn, Julian M W ^a   Elliott, Jan ^a   Gillespie, Matthew T ^a   Martin, T John ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CALCITONIN RECEPTOR; COLONY STIMULATING FACTOR 1; DIFFERENTIATION INDUCING FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0031765480     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.10.6331     Document Type: Article

References (13)

1. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocrine Rev 13: 66-68
2. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Martin TJ, Suda T 1990 Origin of the osteoclast: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow derived cells. Proc Natl Acad Sci USA 87: 7260-7264
3. Fujikawa Y, Quinn JMW, Sabokbar A, McGee JO'D, Athanasou NA 1996 The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137: 4058-4060
4. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T 1993 Macrophage colony stimulating factor is indispensible for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91: 257-263
5. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclast inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 95: 3597-3602
6. Horwood N, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin TJ, Gillespie MT 1998 Interleukin 18 inhibits osteoclast formation via T-cell production of granulocyte-macrophage colony stimulating factor. J Clin Invest 101: 595-603
7. Chambers TJ, Revell PA, Fuller K, Athanasou NA 1984 Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 66: 383-399
8. Athanasou NA, Quinn JM 1990 Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 43: 997-1004
9. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FAO, Martin TJ 1986 Abundant calcitonin receptors in isolated rat osteoclasts. J Clin Invest 78: 355-365
10. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Kalachnikov S, Bartlett F, Frankel W, Lee S, Choi Y 1997 Trance is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T-cells. J Biol Chem 272: 25190-25194
11. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, Dubose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature 390: 175-179
12. Bevilacqua MA, Lord DK, Cross NC, Whitaker KB, Moss DW, Cox TM 1991 Regulation and expression of type V (tartrate-resistant) acid phosphatase in human mononuclear phagocytes. Mol Biol Med 8: 135-140
13. Stern M, Savill J, Haslett C 1996 Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol 149: 911-921